Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study.

[1]  A. Apisarnthanarak,et al.  Risk Factors and Outcomes of Carbapenem-resistant Acinetobacter baumannii Bacteremia in Neonatal Intensive Care Unit: A Case-case-control Study , 2013, The Pediatric infectious disease journal.

[2]  B. Betsch,et al.  Transmission Dynamics of Extended-Spectrum β-lactamase–Producing Enterobacteriaceae in the Tertiary Care Hospital and the Household Setting , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Yun Xia,et al.  Characterization of Carbapenemase Genes in Enterobacteriaceae Species Exhibiting Decreased Susceptibility to Carbapenems in a University Hospital in Chongqing, China , 2012, Annals of laboratory medicine.

[4]  P. Nordmann,et al.  Carbapenem resistance in Enterobacteriaceae: here is the storm! , 2012, Trends in molecular medicine.

[5]  Tsu‐Lan Wu,et al.  Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case-control study. , 2011, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[6]  K. Ko,et al.  Bloodstream Infections and Clinical Significance of Healthcare-associated Bacteremia: A Multicenter Surveillance Study in Korean Hospitals , 2010, Journal of Korean medical science.

[7]  P. Della‐Latta,et al.  Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. , 2010, Diagnostic microbiology and infectious disease.

[8]  Ronald N. Jones,et al.  Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). , 2009, Diagnostic microbiology and infectious disease.

[9]  D. Nicolau,et al.  Risk Factors and Outcomes Associated with Isolation of Meropenem High-Level-Resistant Pseudomonas aeruginosa , 2009, Infection Control & Hospital Epidemiology.

[10]  Yehuda Carmeli,et al.  Carbapenem-resistant Enterobacteriaceae: a potential threat. , 2008, JAMA.

[11]  J. Campos,et al.  Emergence of imipenem resistance in clinical Escherichia coli during therapy. , 2008, International journal of antimicrobial agents.

[12]  A. Hidrón,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.

[13]  N. Woodford,et al.  Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. , 2008, International journal of antimicrobial agents.

[14]  A. Vatopoulos.  High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  Fotini C Chelvatzoglou,et al.  Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. , 2007, The Journal of antimicrobial chemotherapy.

[16]  K. Bush,et al.  Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.

[17]  S. Choi,et al.  Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. , 2006, Diagnostic microbiology and infectious disease.

[18]  T. Gootz,et al.  High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of blaACT-1 β-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE , 2006, Antimicrobial Agents and Chemotherapy.

[19]  Y. Carmeli,et al.  Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in Israel , 2006, Antimicrobial Agents and Chemotherapy.

[20]  W. Bilker,et al.  Imipenem Resistance Among Pseudomonas aeruginosa Isolates Risk Factors for Infection and Impact of Resistance on Clinical and Economic Outcomes , 2006, Infection Control & Hospital Epidemiology.

[21]  S. Choi,et al.  Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. , 2005, Microbial drug resistance.

[22]  Baha Abdalhamid,et al.  Escherichia coli: development of carbapenem resistance during therapy. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  P. Nordmann,et al.  In Vivo Acquisition of High-Level Resistance to Imipenem in Escherichia coli , 2004, Journal of Clinical Microbiology.

[24]  D. Schwartz,et al.  Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  A. Harris.  Control group selection is an important but neglected issue in studies of antibiotic resistance. , 2000, Annals of internal medicine.

[26]  G. French,et al.  Carbapenem Resistance in Escherichia coli Associated with Plasmid-Determined CMY-4 β-Lactamase Production and Loss of an Outer Membrane Protein , 1999, Antimicrobial Agents and Chemotherapy.

[27]  Suvarna Sk,et al.  Morphological changes in Pseudomonas aeruginosa secondary to ciprofloxacin. , 1997 .

[28]  G. Aubert,et al.  Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy. , 1992, The Journal of antimicrobial chemotherapy.

[29]  A. Kampen,et al.  A matched case-control study of 13 patients , 2009 .

[30]  Iraida E. Robledo,et al.  Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. , 2009, MMWR. Morbidity and mortality weekly report.

[31]  S. Suvarna,et al.  Morphological changes in Pseudomonas aeruginosa secondary to ciprofloxacin. , 1997, Histopathology.